Indications

Mebhydrolin Napadisylate is indicated in- Allergic disease or symptoms such as urticaria Pruritus of various origin Eczema Itching Drug rash Insect bites Allergic conjunctivitis Dermatitis of nutritional origin Hay fever Vasomotor rhinitis Allergic asthma.

Composition

Pharmacology

Mebhydrolin diminishes or abolishes the main actions of histamine in the body by blocking of histamine receptors.

Dosage & Administration

Adults and children over 10 years: 2-6 tablets daily Children- 5-10 years: 2-4 tablets daily 2-5 years: 1-3 tablets daily Up to 2 years: 1-2 tablets daily Treatment should be given in several single doses daily. Mebhydrolin may be swallowed during or shortly after meals. For children, the tablet may be crushed and mixed with food.

Contraindications

Hypersensitivity to any of the ingredients of Mebhydrolin tablet or to mebhydrolin Prostatic hypertrophy, narrow-angle glaucoma. First trimester of pregnancy.

Side Effects

Lassitude, dizziness, hypotension, muscular weakness, nausea, vomiting, diarrhoea or constipation, epigastric pain, headache, blurred vision, tinnitus, depression, nightmares, anorexia, dryness of the mouth, tightness of the chest, tingling, sedation, drowsiness etc. may occur.

Pregnancy & Lactation

Safety in pregnancy and lactation has not been established.

Precautions & Warnings

The substance may cause drowsiness, if affected, driving or operating machinery & alcoholic drinks should be avoided.

Therapeutic Class

Sedating Anti-histamine

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.